Sanquin participates in Dendritic Cell-consortium DC4Balance

Sanquin Researchers Professor Marieke van Ham and dr. Anja ten Brinke participate in a large Dutch consortium named DC4Balance.

A PPS-SGF-Immunology grant (funded by HealthHolland) has been issued to the DC4Balance consortium, headed by Jolanda de Vries (RadboudUMC) and Esther de Jong (Amsterdam UMCAMC). In this consortium 8 Dutch research institutes, among which Sanquin, and 12 companies participate.

Together they aim to gain disease-overarching insight in Dendritic cell (DC) modulating therapeutics, by developing a harmonised immunological toolbox to analyze the unique longitudinal patient samples present within the consortium from (recently) performed immunotherapy trials in different diseases, such as cancer, autoimmunity and allergy.

In addition, the team aspires to devise smart nanosystems that can find, modulate and activate DCs inside the body, rather than modulating DCs outside the body.